Search

everythinglearnresearchcommunity

for

Search:↓

Exosomes from Pinctada martensii mucus can safely reduce melanin production, offering a new treatment for skin pigment issues.

The gp130 receptor helps in tissue regeneration and disease progression, and manipulating it could improve healing and prevent disease.

Erlotinib can cause hair loss as a side effect.

The drug combination was safe and showed promise in treating advanced tumors.

A woman's hair turned white after taking a cancer drug called dasatinib.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Nilotinib can cause skin issues like red bumps and hair loss.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

Nilotinib can cause generalized keratosis pilaris.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Gefitinib can cause hair and eyebrow darkening.

A man's bald spot grew hair after starting cancer treatment with gefitinib.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Axitinib treatment turned a man's grey hair back to black.

Nilotinib may cause gray hair to return to its original color.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Deucravacitinib helped regrow hair and reduce plaques in a woman with discoid lupus erythematosus without side effects.

Deucravacitinib helped a man regrow hair significantly.

Gefitinib therapy can cause unusual hair growth on the nose.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

Nilotinib can cause keratosis pilaris, a skin condition.

Tyrosine kinase inhibitors effectively treat cancers but often cause skin and other side effects.

Green tea's EGCG has various health benefits, including antioxidant properties, skin protection, cancer cell growth inhibition, anti-inflammatory effects, fat breakdown, detoxification, diabetes management, hair growth stimulation, and prevention of gum disease.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.